Eyed Pharma NV
Eyed Pharma (NV) is a company in Liège, active in research and experimental development on natural sciences and engineering, founded in 2012, with 29 employees (full-time equivalents). Financial year 2025: turnover €10.49m, profit -€6.92m, equity €17.37m.
2 warnings: 2025 annual accounts filed late, three consecutive years of losses2 points of attentionShowHide
- Explained →
2025 annual accounts filed late. Filed on 22/09/2026, 53 days after the legal deadline.
Source: NBB, filed on 22/09/2026 - Explained →
Three consecutive years of losses. Loss in 2023, 2024, 2025 (€ -6,921,488 in 2025).
Source: NBB, annual accounts 2023 to 2025
Figures for Eyed Pharma, 2025NBB · abridged format
All figures, sector and health →Three ratios
How we calculateAnnual accounts 2025. The sector is recalculated every night.
See everything about Eyed Pharma
Health check, financial year in detail, 10 years of history and the board.
What happenedfrom the annual accounts and the CBE
- Annual accounts 2025 filed
- Annual accounts 2024 filed
- Annual accounts 2023 filed
- Incorporated as naamloze vennootschap
Activities NACE-BEL 2025
Establishments 1
- Rue Louis Plescia 9, 4102 Seraing · since 20/12/20122.218.862.726
AuditProSanctions and politically exposed persons
Is a director on a sanctions list, or do they share the name of a politically exposed person? You can see it with Nummo Pro. Start your free trial
Publications in the Belgian Official Gazette 21 publications
- 13/10/2026BoardRegistered officeSiege social, demissions, nominationsDeed (pdf)
- 28/04/2026CapitalCapital, actionsDeed (pdf)
- 18/11/2025BoardDemissions, nominationsDeed (pdf)
All 21 publications → list, timeline or per year
E-invoicing and VAT
Checking… · Peppol network and European VAT register (VIES)Read more